No age is a good age to develop breast cancer. Though it most often strikes women between the ages of 55 and 65, women of all ages should be aware of their personal risk factors and be diligent about screenings.
It’s 7:15 a.m. and you have just enough time to get a jacket off the pile of clothes on your treadmill, grab a cold toaster pastry, and get the kids out the door to school. If you’re like most women, that scenario doesn’t leave a lot of time for thinking about your health. But, making a few adjustments to your hectic routine could help prevent breast cancer.
The latest technology in breast cancer detection is now available at Adventist GlenOaks Hospital. The hospital recently installed a new Selenia® Dimensions® two-dimensional full-field digital mammography system, the latest available diagnostic technology for increasing the early detection of breast cancer. The hospital also remodeled the mammography suite to be more patient-centric.
New patient-centered suites and digital mammograms are helping diagnose breast cancer in its early, most treatable stages.
Adventist Midwest Health kicked off Breast Cancer Awareness Month with tree-lighting ceremonies and art contests. The four suburban hospitals held simultaneous celebrations the evening of Sept. 29, turning on pink lights across the hospital campuses – both outdoors and inside – to draw attention to the observance of October as Breast Cancer Awareness Month.
It seems the more we know about prostate cancer, the more difficult it is to accurately predict who will develop it and who won’t. With the likelihood that one in six American men will be diagnosed in his lifetime, the odds are high – especially if you’re above age 60, African-American and/or have a family history of the disease. Even if you don’t fit those important risk factors, there are some wild cards, such as diet, exercise and early screenings, you can play to your advantage.
Most traditional prostate cancer treatment plans consist of three main options: surgery, radiation and chemotherapy. While the majority of prostate cancer patients will still undergo some combination of those three treatments, there are alternative treatments available for select groups of patients. For patients with early stage prostate cancer, hormone therapy can often stall cancer cell production as a precursor to traditional treatment. Meanwhile, men with late stage prostate cancer may find hope in a new immunotherapy treatment.